COLLEGIUM PHARMACEUTICAL, INC (COLL) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001267565 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $199.9M | $-15.1M | $-0.46 | Filing |
| Mar 31, 2026 | May 7, 2026 | $193.5M | $14.5M | $0.40 | Filing |
| Dec 31, 2025 | Feb 26, 2026 | $205.4M | $17.0M | $0.46 | Filing |
| Sep 30, 2025 | Nov 6, 2025 | $209.4M | $31.5M | $0.84 | Filing |
| Jun 30, 2025 | Aug 7, 2025 | $188.0M | $12.0M | $0.34 | Filing |
| Mar 31, 2025 | May 8, 2025 | $177.8M | $2.4M | $0.07 | Filing |
| Dec 31, 2024 | Feb 27, 2025 | $181.9M | $12.5M | $0.36 | Filing |
| Sep 30, 2024 | Nov 7, 2024 | $159.3M | $9.3M | $0.27 | Filing |
What would COLLEGIUM PHARMACEUTICAL, INC have to report for its valuation to change?
At $23.19, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 9.8% a year, to $1.98. On that path the next quarter needs diluted EPS near $0.92, against $0.84 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 9.8% | 9.8% |
| EPS needed in final year | $1.98 | $1.98 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. COLL goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.